Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Product List of all Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Noramco

    Client Virtual Booth

    NORAMCO

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    • Buprenorphine

    • Buprenorphine Hydrochloride

    • Gamma-Hydroxybutyric Acid

    • Lisdexamfetamine Dimesylate

    • Sodium Oxybate

    INTERMEDIATES

    INSPECTIONS & REGISTRATIONS

    OTHER PRODUCTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Normaco
    Noramco
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    500 Swedes Landing Rd, Wilmington, DE 19801
    Telephone
    Telephone
    +1 3026523840
    Client Email
    Email
    aambrosi@Noramco.com
    Client Website
    Website
    https://www.noramco.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/noramco-inc-/
    Twitter
    Twitter
    Contact Info
    Others

    left grey arrow
    right gray arrow
    ListList of Products
    Full View ScreenFull Screen View
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

    Naltrexone Hydrochloride

    PDF Supplier PDF
    URL Supplier Web Content
    See all info for this product

    See Less

    USDMF

    Found USDMF

    23325
    Active
    NALTREXONE HYDROCHLORIDE DRUG SUBST...
    2009-12-01
    CEP/COS

    Found CEP/COS

    R0-CEP 2020-291 - Rev 01
    Valid
    Naltrexone hydrochloride, Wavelengt...
    2022-03-17
    Japanese DMF

    Close JDMF

    Written Confirmation

    Close WC

    Application Number
    23325
    R0-CEP 2020-291 - Rev 01
    Status
    Active
    Fees Paid
    Reviewed
    Valid
     
    Filing Details
    NALTREXONE HYDROCHLORIDE DRUG SUBST...
    Naltrexone hydrochloride, Wavelengt...
    Issue/Submission Date
    2009-12-01
    2022-03-17
    Noramco

    CPhI North America

    Attending

    envelop Contact Supplier

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Access Website

    Contact Supplier

    View Presentation

    Normaco

    CPhI North America

    Attending

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search